Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26FF0T9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,207
Award facts
- Contract value 100% obligated
- $37,206.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of 500 tablets of Ondansetron HCl 4 mg, a commonly prescribed anti-nausea medication. This firm fixed-price delivery order, valued at $37,206.66, is scheduled for completion by January 14, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without any set-aside designation, indicating full and open competition. This delivery order represents a task order issued under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular order for Ondansetron reflects the routine pharmaceutical supply operations through which AmerisourceBergen fulfills critical medication needs for military treatment facilities and federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FF0T9?
SPE2DR26FF0T9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FF0T9 worth?
The government has obligated $37,207 on SPE2DR26FF0T9.
Is contract SPE2DR26FF0T9 an order under another contract?
Yes. SPE2DR26FF0T9 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FF0T9 competed?
The extent of competition for SPE2DR26FF0T9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award